doxazosin plus tolterodine SR
2008-08-092
Approved small_molecule completed
Quick answer
doxazosin plus tolterodine SR for Overactive Bladder is a Approved program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Overactive Bladder
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed